Navigation Links
Varian, Inc. Offers New Products for the Rapid Purification of Synthetic Oligonucleotides.
Date:10/31/2007

LAKE FOREST, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Varian, Inc. (Nasdaq: VARI) announced today two new TOP (Trityl-on Oligonucleotide Purification) products, TOP-DNA and TOP-RNA, for the purification of synthetic oligonucleotides (oligos).

Synthetic DNA and RNA oligos are used by life science researchers to study the functions of genes and proteins within cells. For oligos to work properly, salts and incomplete products need to be removed from the synthesis mixture. Both TOP products allow full length oligos to bind to the sorbent bed while salts, incomplete oligos and other impurities are washed away. Subsequent cleavage of the protective dimethoxytrityl ("trityl") groups releases the purified completed product. Purification and de-tritylation within the TOP cartridge results in higher yields and greater purity of synthesized product in less time than with alternative methods.

TOP-DNA is designed to purify both short and long DNA oligos using a common method. TOP-RNA is a complete solution that includes cartridges and proprietary buffers specifically for RNA oligos.

"TOP-DNA and TOP-RNA extend the TOP line of products," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "Varian's TOP products make it easier for the synthesizers of oligos to deliver more products to their customers in less time."

For more technical information about Varian's Biosolutions, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum components, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people and operates manufacturing facilities in 13 locations in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

Varian and the Varian Logo are trademarks of Varian, Inc.

For More Information, Contact:

Public Relations

Varian, Inc.

650.424.3845

pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Roche offers HIV drug expertise to poor nations
5. Magnesium sulfate offers no help in migraine treatment
6. Drug Offers Hope for Alzheimers disease
7. Drug Firm Offers to Donate Smallpox Vaccine
8. fMRI Offers Insight Into An Infants Brain
9. Gel Offers A More Targeted Approach
10. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
11. Surgery Offers Better Treatment For Third Degree Piles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that ... you are not alone. According to the Center for Disease Control and Prevention (CDC), ... 2 diabetes and certain types of cancer, some of the leading causes of preventable ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Association of Home ... and the Home Health and Hospice ICD-10 Transition Workgroup are working closely with ... guidance and clarifications, to address concerns over the use of 'A' as the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... NORRITON, Pa. , Feb. 8, 2016 /PRNewswire/ ... of November Research Group (NRG),s pharmacovigilance technology ... pharmacovigilance system-related consulting services and an Oracle Argus ... compliance services to Life Sciences companies. ... strengthens and expands HighPoint,s life sciences capabilities and ...
(Date:2/8/2016)... Switzerland and PALO ALTO, Calif. , Feb. ... and chemical manufacturing, and Kodiak Sciences Inc., a biopharmaceutical ... of retinal disease, announced today agreements for the clinical ... will manufacture material at multiple sites, including Slough (UK), ... --> --> Retinal diseases, such as ...
(Date:2/8/2016)... 2016  Avista Pharma Solutions ("Avista Pharma") announced today ... Financial Officer (CFO). Mr. Setzer is a finance and ... various roles within growing technology and life science companies. ... Executive Director of Finance at INC Research, a publicly ... . Previously, Mr. Setzer served as CFO of ...
Breaking Medicine Technology: